Global /Saudi Arabia /Healthcare /Drug Manufacturers - General /4016

Middle East Pharmaceutical Industries Co.

4016

• TADAWUL: 4016 • Delayed

103.50SAR 0.6%

27.57 USD

As of 10 June 2026, Middle East Pharmaceutical Industries Co. has a market cap of $550.29M USD, ranking #14486 globally and #131 in Saudi Arabia. It ranks #1289 in the Healthcare sector, and #479 in the Drug Manufacturers - General industry.

Global Rank

14486

Country Rank

131

Sector Rank

1289

Industry Rank

479

Key Stats

Market Cap

$550.29MUSD

2.07B SAR

Enterprise Value

$558.14MUSD

2.1B SAR

Revenue (TTM)

$122.65MUSD

460.48M SAR

EBITDA (TTM)

$31.73MUSD

119.12M SAR

Net Income (TTM)

$25.84MUSD

97.01M SAR

EBITDA Margin

26%

Profit Margin

21%

PE Ratio

21.3

PS Ratio

4.5

PB Ratio

5.0

EV/EBITDA

17.6

Company Profile

Country (HQ)

Saudi Arabia

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mohammed Maher Al-Ghannam open_in_new

Employees

731

Founded

1998

Website

avalonpharmaceutical.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.6%	-0.5%	5.3%	-7.9%	-23%	-6.9%	-20%	18%	18%

News

Markets

Exchange	Ticker	Price	Quotes
Saudi Exchange (TADAWUL) MIC: XSAU PRIMARY	4016 Middle East Pharmaceutical Industries Co ISIN: SA160G51UO10 Shares Out.: Shares Outstanding: 35.0M¹ Shares Float: 15.096M² TV: TradingView: TADAWUL: 4016 SA: Stock Analysis: TADAWUL: 4016 YF: Yahoo Finance: 4016.SR GF: Google Finance: TADAWUL: 4016 BA: Barron's: 4016 MS: Morningstar: XSAU: 4016	103.50 SAR	TV: TradingView: TADAWUL: 4016 SA: Stock Analysis: TADAWUL: 4016 YF: Yahoo Finance: 4016.SR GF: Google Finance: TADAWUL: 4016 BA: Barron's: 4016 MS: Morningstar: XSAU: 4016

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Middle East Pharmaceutical Industries Co.

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. Its product portfolio includes dermatological, respiratory, cardiovascular, alimentary and anti-infectives, musculoskeletal, genitourinary systems, and CNS. It exports its products. The company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006. Middle East Pharmaceutical Industries Company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.

Similar Companies

Industry: Drug Manufacturers - General (Saudi Arabia)

Name	Market Cap (USD) diff.	PE	Country
Astra Industrial Group Co. TADAWUL: 1212	$3.01B 11.3B SAR 447%	17.0	Saudi Arabia
Jamjoom Pharmaceuticals Factory Co. TADAWUL: 4015	$2.91B 10.92B SAR 429%	23.5	Saudi Arabia
Saudi Pharmaceutical Industries and Medical Appliances Corp. TADAWUL: 2070	$984.24M 3.7B SAR 79%	20.0	Saudi Arabia
Qomel Company Ltd. TADAWUL: 9600	$95.65M 359.1M SAR -83%	24.0	Saudi Arabia

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 138K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 99K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 65K%	97.4	United States
Roche Holding AG SIX: RO	$321.16B 256.25B CHF 58K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.62B 215.59B GBP 52K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.35B 218.9B CHF 50K%	20.5	Switzerland

chevron_leftBack